Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating the IL-23/IL-23R Axis in Acute Myeloid Leukemia

FY 2021-22

Summary
My proposed research involves looking at the interleukin-23/interleukin-23 receptor (IL-23/IL-23R) pathway in the context of acute myeloid leukemia (AML). Preliminary data for this project indicates a dependency on IL-23R by various AML cell lines. By genetically modifying these cell lines and making them incapable of producing IL-23R, we see a reduction in AML cell growth and viability. Additionally, when looking at the expression of IL-23R in primary AML patient samples, we see an increased expression of IL-23R compared to normal peripheral blood stem cells. Exploring this pathway further may prove beneficial in discovering a novel therapeutic target for the treatment of AML. Specifically, I plan to get a better understanding of IL-23 and IL-23R expression in primary AML and normal hematopoietic cells. Preliminary data shows that there appears to be a unique expression and localization pattern in our AML cell lines compared to what has been previously described in the literature for other diseases. Expanding our analysis on primary AML samples can benefit our understanding of this pathway and find potential correlations between expression and known molecular subtypes of AML.Secondly, due to the reductions in cell growth and viability of our AML cell lines when genetically modifying IL-23R, I plan to look at potential methods of pharmacological inhibition against this pathway as it may prove beneficial in discovering a novel therapy for AML. Lastly, it was seen in our data that AML cell lines and patient samples had a unique expression and localization of IL-23R. This has not been previously described in current literature. I plan on studying this signalling pathway within AML by studying the cytokine and by looking for AML IL-23R binding partners.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466861
Name
Duong Nathan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the IL-23/IL-23R Axis in Acute Myeloid Leukemia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Interleukin; Mechanism; Therapy
Abstract
My proposed research involves looking at the interleukin-23/interleukin-23 receptor (IL-23/IL-23R) pathway in the context of acute myeloid leukemia (AML). Preliminary data for this project indicates a dependency on IL-23R by various AML cell lines. By genetically modifying these cell lines and making them incapable of producing IL-23R, we see a reduction in AML cell growth and viability. Additionally, when looking at the expression of IL-23R in primary AML patient samples, we see an increased expression of IL-23R compared to normal peripheral blood stem cells. Exploring this pathway further may prove beneficial in discovering a novel therapeutic target for the treatment of AML. Specifically, I plan to get a better understanding of IL-23 and IL-23R expression in primary AML and normal hematopoietic cells. Preliminary data shows that there appears to be a unique expression and localization pattern in our AML cell lines compared to what has been previously described in the literature for other diseases. Expanding our analysis on primary AML samples can benefit our understanding of this pathway and find potential correlations between expression and known molecular subtypes of AML.Secondly, due to the reductions in cell growth and viability of our AML cell lines when genetically modifying IL-23R, I plan to look at potential methods of pharmacological inhibition against this pathway as it may prove beneficial in discovering a novel therapy for AML. Lastly, it was seen in our data that AML cell lines and patient samples had a unique expression and localization of IL-23R. This has not been previously described in current literature. I plan on studying this signalling pathway within AML by studying the cytokine and by looking for AML IL-23R binding partners.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Duong, Nathan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~